“…Drug therapy. Criticism directed toward drug therapy in the management of diabetic retinopathy is justifiable, in view of the initial, but transient, enthusiasm for the host of agents that have failed to live up to the claims made for them (3–10). Furthermore, one has to consider wide variations in the rate of resorption of intraocular hemorrhages.…”